ACE Inhibitors News and Research

RSS
ACE inhibitors act to reduce hypertension by interfering with the conversion of angiotensin I to artery-constricting angiotensin II. Blocking the production of angiotensin II results in arterial vasodilation and an accompanying reduction in blood pressure. ACE inhibitors currently are recommended as first-line therapy for hypertension in certain patient populations, because of their safety and efficacy.
ARAMIS trial finds no benefit of anakinra in acute myocarditis

ARAMIS trial finds no benefit of anakinra in acute myocarditis

Patients affected by depression more likely to stop taking their heart medications

Patients affected by depression more likely to stop taking their heart medications

The link between Covid-19 and Alzheimer's disease established

The link between Covid-19 and Alzheimer's disease established

Young women who experience a heart attack more likely to be rehospitalized after discharge

Young women who experience a heart attack more likely to be rehospitalized after discharge

Virtual care team strategy found to be safe and effective in improving treatment for heart failure patients

Virtual care team strategy found to be safe and effective in improving treatment for heart failure patients

MINOCA: Insights into a type of heart attack that predominantly affects women

MINOCA: Insights into a type of heart attack that predominantly affects women

UT Southwestern physician-scientist wins NIH award to support heart regeneration research

UT Southwestern physician-scientist wins NIH award to support heart regeneration research

Dapagliflozin improves morbidity reduces risk of death in heart failure patients

Dapagliflozin improves morbidity reduces risk of death in heart failure patients

Metformin reduces risk of severe COVID-19 in diabetic patients

Metformin reduces risk of severe COVID-19 in diabetic patients

Aldosterone may increase risk of kidney failure in patients with chronic kidney disease

Aldosterone may increase risk of kidney failure in patients with chronic kidney disease

Diabetes patients on Medicare Advantage plans less likely to be prescribed newer, more expensive medicines

Diabetes patients on Medicare Advantage plans less likely to be prescribed newer, more expensive medicines

Drug combinations may help to slow the progression of diabetic kidney disease

Drug combinations may help to slow the progression of diabetic kidney disease

Assessment of England's medication prescribing safety during COVID pandemic

Assessment of England's medication prescribing safety during COVID pandemic

Personalized text messaging program improves healthy lifestyle measures in heart attack survivors

Personalized text messaging program improves healthy lifestyle measures in heart attack survivors

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Understanding sex differences in the pathophysiology of SARS-CoV-2 infection

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

Severe COVID linked to RAAS and hyperlipidemia associated metabolic syndrome conditions

Gut bacterium may be an important factor in resistance to antihypertensive medications

Gut bacterium may be an important factor in resistance to antihypertensive medications

Patiromer lowers hyperkalemia risk in heart failure patients taking RAASi therapy

Patiromer lowers hyperkalemia risk in heart failure patients taking RAASi therapy

Long-term use of blood pressure medication could be contributing to kidney damage

Long-term use of blood pressure medication could be contributing to kidney damage

A closer look at the relationship between COVID-19 and Alzheimer’s disease

A closer look at the relationship between COVID-19 and Alzheimer’s disease